The role focuses on improving an AI model that identifies patients likely to have transthyretin (ATTR) cardiac amyloidosis through clinical chart review and evidence-based reasoning.

• Engagement: Part-time consulting with a commitment of 10–20 hours per week.
• Required Role: US-based clinicians only.
• Focus: Patient chart annotation, clinical reasoning, and AI model improvement.

Contract and Payment Terms

• You will be engaged as an independent contractor.
• This is a fully remote role that can be completed on your own schedule.
• Projects can be extended, shortened, or concluded early depending on needs and performance.
• Your work at Mercor will not involve access to confidential or proprietary information from any employer, client, or institution.
• Payments are weekly on Stripe or Wise based on services rendered.
• Please note: We are unable to support H1-B or STEM OPT candidates at this time.

• Review patient charts and assess the likelihood of ATTR cardiac amyloidosis, including cases with incomplete information.
• Document clinical reasoning using specific, evidence-based criteria; distinguish ATTR from similar conditions and communicate uncertainty.
• Apply consistent labeling standards and refine assessments based on new evidence and AI model feedback.
• Explain clinical decisions clearly to engineers and data scientists and complete labeling batches within agreed timelines.

Work arrangement: Fully remote

Eligible countries: United States